1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Real Time- PCR Systems
1.2.3 Liquid Handling System
1.2.4 NA Extraction System
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Academic and Research Institutes
1.3.5 Pharmaceutical and Biotechnology Companies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Market Perspective (2017-2028)
2.2 Molecular Diagnostics Growth Trends by Region
2.2.1 Molecular Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Molecular Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Molecular Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Molecular Diagnostics Market Dynamics
2.3.1 Molecular Diagnostics Industry Trends
2.3.2 Molecular Diagnostics Market Drivers
2.3.3 Molecular Diagnostics Market Challenges
2.3.4 Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Players by Revenue
3.1.1 Global Top Molecular Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Molecular Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Revenue
3.4 Global Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Revenue in 2021
3.5 Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Breakdown Data by Type
4.1 Global Molecular Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Molecular Diagnostics Forecasted Market Size by Type (2023-2028)
5 Molecular Diagnostics Breakdown Data by Application
5.1 Global Molecular Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Molecular Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Molecular Diagnostics Market Size (2017-2028)
6.2 North America Molecular Diagnostics Market Size by Country (2017-2022)
6.3 North America Molecular Diagnostics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Molecular Diagnostics Market Size (2017-2028)
7.2 Europe Molecular Diagnostics Market Size by Country (2017-2022)
7.3 Europe Molecular Diagnostics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Molecular Diagnostics Market Size by Country (2017-2022)
8.3 Asia-Pacific Molecular Diagnostics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Market Size (2017-2028)
9.2 Latin America Molecular Diagnostics Market Size by Country (2017-2022)
9.3 Latin America Molecular Diagnostics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Molecular Diagnostics Market Size by Country (2017-2022)
10.3 Middle East & Africa Molecular Diagnostics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Molecular Diagnostics Introduction
11.1.4 Agilent Technologies Revenue in Molecular Diagnostics Business (2017-2022)
11.1.5 Agilent Technologies Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics Introduction
11.2.4 BD Revenue in Molecular Diagnostics Business (2017-2022)
11.2.5 BD Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Molecular Diagnostics Introduction
11.3.4 Bio-Rad Laboratories Revenue in Molecular Diagnostics Business (2017-2022)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Molecular Diagnostics Introduction
11.4.4 Danaher Revenue in Molecular Diagnostics Business (2017-2022)
11.4.5 Danaher Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Molecular Diagnostics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Molecular Diagnostics Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Eppendorf
11.6.1 Eppendorf Company Detail
11.6.2 Eppendorf Business Overview
11.6.3 Eppendorf Molecular Diagnostics Introduction
11.6.4 Eppendorf Revenue in Molecular Diagnostics Business (2017-2022)
11.6.5 Eppendorf Recent Development
11.7 PerkinElmer
11.7.1 PerkinElmer Company Detail
11.7.2 PerkinElmer Business Overview
11.7.3 PerkinElmer Molecular Diagnostics Introduction
11.7.4 PerkinElmer Revenue in Molecular Diagnostics Business (2017-2022)
11.7.5 PerkinElmer Recent Development
11.8 Tecan Group
11.8.1 Tecan Group Company Detail
11.8.2 Tecan Group Business Overview
11.8.3 Tecan Group Molecular Diagnostics Introduction
11.8.4 Tecan Group Revenue in Molecular Diagnostics Business (2017-2022)
11.8.5 Tecan Group Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Detail
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Molecular Diagnostics Introduction
11.9.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Business (2017-2022)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 QIAGEN
11.10.1 QIAGEN Company Detail
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Molecular Diagnostics Introduction
11.10.4 QIAGEN Revenue in Molecular Diagnostics Business (2017-2022)
11.10.5 QIAGEN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
